<DOC>
	<DOC>NCT02872818</DOC>
	<brief_summary>The purpose of the study is to determine apoptotic signaling pathways such as Survivin, Bcl-2, Bax, c-Myc and caspase-9 expression levels in rats model with iatrogenic endometrial hyperplasia after metformin and medroxyprogesterone acetate administration.</brief_summary>
	<brief_title>Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Endometrial Hyperplasia</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Medroxyprogesterone</mesh_term>
	<mesh_term>Medroxyprogesterone Acetate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Inclusion criteria: Fortyeight weeks old female WistarAlbino rats, weighting between 180 and 260 g Exclusion criteria. We have no exclusion criteria because we examine drugs effects in the experimental rats</criteria>
	<gender>Female</gender>
	<minimum_age>8 Weeks</minimum_age>
	<maximum_age>10 Weeks</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Apoptotic signal pathway</keyword>
	<keyword>Survivin</keyword>
	<keyword>Bcl-2</keyword>
	<keyword>Bax</keyword>
	<keyword>c-Myc</keyword>
	<keyword>Caspase-9</keyword>
	<keyword>endometrial hyperplasia</keyword>
	<keyword>endometrium cancer</keyword>
</DOC>